Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: a review of their validity .

endogenous psychosis Kleist Leonhard Wernicke affect laden paraphrenia bipolar cataphasia catatonia classification cycloid psychoses deep phenotyping epistemology hebephrenia periodic catatonia phenotype schizophrenia supersensitivity psychosis system schizophrenia unipolar

Journal

Dialogues in clinical neuroscience
ISSN: 1958-5969
Titre abrégé: Dialogues Clin Neurosci
Pays: England
ID NLM: 101238198

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 15 7 2021
Statut: ppublish

Résumé

While the ICD-DSM paradigm has been a major advance in clinical psychiatry, its usefulness for biological psychiatry is debated. By defining consensus-based disorders rather than empirically driven phenotypes, consensus classifications were not an implementation of the biomedical paradigm. In the field of endogenous psychoses, the Wernicke-Kleist-Leonhard (WKL) pathway has optimized the descriptions of 35 major phenotypes using common medical heuristics on lifelong diachronic observations. Regarding their construct validity, WKL phenotypes have good reliability and predictive and face validity. WKL phenotypes come with remarkable evidence for differential validity on age of onset, familiality, pregnancy complications, precipitating factors, and treatment response. Most impressive is the replicated separation of high- and low-familiality phenotypes. Created in the purest tradition of the biomedical paradigm, the WKL phenotypes deserve to be contrasted as credible alternatives with other approaches currently under discussion.
. Mettre la traduction ES. Mettre la traduction FR.

Autres résumés

Type: Publisher (spa)
Mettre la traduction ES.
Type: Publisher (fre)
Mettre la traduction FR.

Identifiants

pubmed: 32699504
doi: 10.31887/DCNS.2020.22.1/jfoucher
pmc: PMC7365293
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-49

Informations de copyright

© 2019, AICHServier GroupCopyright © 2019 AICH Servier Group. All rights reserved.

Références

Front Psychol. 2015 Jul 16;6:971
pubmed: 26236257
Schizophr Bull. 2017 Sep 1;43(5):972-981
pubmed: 27729486
Biol Psychiatry. 1974 Feb;8(1):23-45
pubmed: 4815341
Am J Med Genet. 1996 May 31;67(3):289-300
pubmed: 8725746
Assessment. 2009 Jun;16(2):127-44
pubmed: 19234296
Am Psychol. 1992 Mar;47(3):373-88
pubmed: 1562108
Am J Psychiatry. 1970 Jan;126(7):983-7
pubmed: 5409569
Compr Psychiatry. 1985 Mar-Apr;26(2):148-56
pubmed: 3886277
J Affect Disord. 2004 Nov 15;83(1):11-9
pubmed: 15546641
J Neural Transm (Vienna). 2002 May;109(5-6):921-9
pubmed: 12111478
Psychopathology. 1990;23(4-6):259-62
pubmed: 2084778
Gene. 2018 Mar 30;648:42-53
pubmed: 29339073
Psychopharmacology (Berl). 1999 Mar;142(4):393-8
pubmed: 10229064
Biol Mood Anxiety Disord. 2011 Nov 07;1(1):9
pubmed: 22738250
Neuropsychobiology. 2020;79(4-5):352-365
pubmed: 31505494
J Ment Sci. 1952 Jan;98(410):66-80
pubmed: 14898208
FEBS J. 2017 May;284(10):1437-1454
pubmed: 27926992
Eur Arch Psychiatry Clin Neurosci. 2008 Sep;258(6):324-34
pubmed: 18299789
Eur Arch Psychiatry Clin Neurosci. 1991;241(3):187-92
pubmed: 1790165
Psychiatr Clin North Am. 2012 Sep;35(3):557-69
pubmed: 22929866
Schizophr Bull. 2008 Jul;34(4):591-4
pubmed: 18492660
Acta Psychiatr Scand Suppl. 2007;(433):5-13
pubmed: 17280565
Biol Psychiatry. 1996 Dec 15;40(12):1255-66
pubmed: 8959290
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:363-369
pubmed: 29559372
Eur Arch Psychiatry Clin Neurosci. 2015 Jun;265(4):273-80
pubmed: 25631618
J Clin Child Adolesc Psychol. 2007 Oct-Dec;36(4):654-76
pubmed: 18088222
Psychopathology. 1992;25(2):57-64
pubmed: 1502293
Schizophr Bull. 2016 Jul;42(4):975-83
pubmed: 26707865
Psychopathology. 1990;23(4-6):205-11
pubmed: 2084771
Aust N Z J Psychiatry. 2003 Jun;37(3):327-33
pubmed: 12780472
Psychopathology. 1997 Mar-Apr;30(2):100-5
pubmed: 9168566
Acta Psychiatr Scand Suppl. 1959;34(136):388-93
pubmed: 13794902
Am J Hum Genet. 2000 Nov;67(5):1201-7
pubmed: 11001582
Psychopathology. 1999 Jul-Aug;32(4):192-202
pubmed: 10364729
N Engl J Med. 2012 May 17;366(20):1855-7
pubmed: 22591292
Hum Genet. 2002 Oct;111(4-5):323-30
pubmed: 12384773
Psychiatry Res. 2003 May 1;123(1):65-79
pubmed: 12738344
Psychopathology. 2001 Nov-Dec;34(6):305-11
pubmed: 11847490
Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):48-58
pubmed: 14601036
Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 1:I21-4
pubmed: 11776267
Dialogues Clin Neurosci. 2015 Mar;17(1):19-29
pubmed: 25987860
Nervenarzt. 1976 May;46(5):242-8
pubmed: 934395
Encephale. 1964;53:SUPPL:245-9
pubmed: 14163581
Biol Psychiatry. 1993 Dec 1;34(11):749-52
pubmed: 8292677
Psychopathology. 1990;23(4-6):331-8
pubmed: 1982184
Psychiatr Neurol Med Psychol Beih. 1986;33:97-107
pubmed: 2880358
Acta Psychiatr Scand Suppl. 1974;253:1-77
pubmed: 4532463
J Affect Disord. 2014 Apr;158:37-47
pubmed: 24655763
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1961;202:513-26
pubmed: 14464120
J Affect Disord. 2000 Jan-Mar;57(1-3):95-8
pubmed: 10708820
Acta Psychiatr Scand. 1994 Apr;89(4):285-8
pubmed: 8023696
Psychol Med. 2009 Jul;39(7):1065-76
pubmed: 19000340

Auteurs

Jack R Foucher (JR)

ICube - CNRS UMR 7357, neurophysiology, FMTS, University of Strasbourg, France ; CEMNIS - Noninvasive Neuromodulation Center, University Hospital Strasbourg, France.

Micha Gawlik (M)

Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany.

Julian N Roth (JN)

Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany.

Clément de Crespin de Billy (C)

ICube - CNRS UMR 7357, neurophysiology, FMTS, University of Strasbourg, France; CEMNIS - Noninvasive Neuromodulation Center, University Hospital Strasbourg, France.

Ludovic C Jeanjean (LC)

IICube - CNRS UMR 7357, neurophysiology, FMTS, University of Strasbourg, France; CEMNIS - Noninvasive Neuromodulation Center, University Hospital Strasbourg, France.

Alexandre Obrecht (A)

ICube - CNRS UMR 7357, neurophysiology, FMTS, University of Strasbourg, France; Pôle de Psychiatrie, Santé Mentale et Addictologie, University Hospital Strasbourg, France.

Olivier Mainberger (O)

ICube - CNRS UMR 7357, neurophysiology, FMTS, University of Strasbourg, France. CEMNIS - Noninvasive Neuromodulation Center, University Hospital Strasbourg, France.

Julie M E Clauss (JME)

Pôle de Psychiatrie, Santé Mentale et Addictologie, University Hospital Strasbourg, France. SAGE - CNRS UMR 7363, FMTS, University of Strasbourg, France.

Julien Elowe (J)

Department of Psychiatry, Prangins Psychiatric Hospital (CHUV), Route de Benex, Prangins, Switzerland.

Sébastien Weibel (S)

IPôle de Psychiatrie, Santé Mentale et Addictologie, University Hospital Strasbourg, France; Physiopathologie et Psychopathologie Cognitive de la Schizophrénie - INSERM 1114, FMTS, University of Strasbourg, France.

Benoit Schorr (B)

Pôle de Psychiatrie, Santé Mentale et Addictologie, University Hospital Strasbourg, France; Physiopathologie et Psychopathologie Cognitive de la Schizophrénie - INSERM 1114, FMTS, University of Strasbourg, France.

Marcelo Cetkovich (M)

Institute of Translational and Cognitive Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.

Carlos Morra (C)

ICube - CNRS UMR 7357, neurophysiology, FMTS, University of StInstitute of Translational and Cognitive Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Sanatorio Morra, Córdoba, Argentina.

Federico Rebok (F)

"Servicio de Emergencia", Acute Inpatient Unit, Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina.

Thomas A Ban (TA)

International Network for the History of Neuropsychopharmacology (INHN), Córdoba, Argentina.

Barbara Bollmann (B)

Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Berlin, Germany.

Mathilde M Roser (MM)

Department of Psychiatry, Mondor Hospital France, Creteil, France.

Markus S Hanke (MS)

Universitäre psychiatrische Dienste Bern, Spiez, Switzerland.

Burkhard E Jabs (BE)

Klinik für Psychiatrie and Psychotherapie, Städtisches Klinikum Dresden, Dresden, Germany.

Ernst J Franzek (EJ)

Yes We Can Clinics, Department of Research and Development, Eindhoven, The Netherlands.

Fabrice Berna (F)

Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany; Department of Psychiatry, Prangins Psychiatric Hospital (CHUV), Route de Benex, Prangins, Switzerland.

Bruno Pfuhlmann (B)

IKlinik für Psychiatrie and Psychotherapie, Städtisches Klinikum Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH